INCYTE
Highly Engaged Employees
Manufacturing · Delaware, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1801 Augustine Cut Off, Wilmington, Dela...Phone Number
(302) 498-6700Website
www.incyte.comRevenue
$5.4 BillionStock Symbol
INCYIndustry
About INCYTE
INCYTE Org Chart
Is INCYTE your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if INCYTE had a recent Job posting/layoffs
Product Launch: Get notified when INCYTE launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
INCYTE, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once INCYTE has new funding data
Check if INCYTE has recently received funding, and reach out quickly before it becomes old news!
Check out if INCYTE is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at INCYTE
Earning: See what the market has to say on INCYTE recently announced quarterly report
Recommended Actions
Find VP level buyers at INCYTE
Find 3 more new buyers
Compare Similar Companies to INCYTE
Compare insights from companies similar to INCYTE, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
INCYTE is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INCYTE is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INCYTE.
INCYTE Tech Stack
A closer look at the technologies used by INCYTE
Most Recent Scoops
INCYTE News & Media
Incyte gains $246M non-cash boost from CMS deal | INCY 8-K Filing - Stock Titan
Incyte settles with CMS over Medicaid rebates for Opzelura, reversing $246M of accruals and ending related litigation, with improved gross-to-net and updated guidance ahead.Incyte Stock: Is INCY Outperforming the Healthcare Sector?
Incyte has rallied the healthcare sector over the past year, and analysts remain moderately optimistic about its prospects.Incyte Corporation (INCY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Incyte Corporation (INCY) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 8:40 AM EDTCompany ParticipantsWilliam Meury - CEO &...Incyte bolsters haematology portfolio in $2bn Vega buyout
The Vega acquisition will see Incyte absorb its first-in-class bleeding disorder candidate, VG039.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INCYTE
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome... Read More



